Question explored with the scientific record
Does antiperspirant use increase breast cancer risk, and what did the Linhart 2017 case-control study find?
The short version: the retrieved evidence does not contain the Linhart 2017 study, and nothing here shows antiperspirant use raising breast cancer risk.
I cannot tell you what Linhart 2017 found. That study is not in the records I was given, and I will not invent its numbers or its conclusion. What the retrieval does contain is a 2023 review of aluminum exposure, and its verdict is that aluminum's critical known harm is neurotoxicity, while causal links to Alzheimer's disease and breast cancer remain unproven [1]. That is a narrative review, not a trial, so it is a summary of opinion and existing data, not proof either way.
The rest of the records are about breast cancer incidence trends, not antiperspirant. They show incidence rising over decades in several countries [2][3][4], and one US analysis ties a 2003 dip to women stopping hormone replacement therapy, not to deodorant [5]. None of these studies measured antiperspirant use at all. So they cannot support or refute a link. The honest read: the mechanism story (aluminum absorbed through shaved skin, acting near breast tissue) is plausible enough to study, but this search surfaced no case-control or cohort data on it.
| What the records show | Finding | Bears on antiperspirant? |
|---|---|---|
| Aluminum review [1] | Breast cancer link unproven | Indirect only |
| US incidence dip 2003 [5] | Tied to HRT drop | No |
| Spain trends [2] | Rise under 45 | No |
| Global trends [4] | Rising incidence, falling death | No |
My call: on this evidence there is no demonstrated link between antiperspirant use and breast cancer, but the specific Linhart 2017 result is not in front of me and I will not fabricate it. Confidence: low, because the key study is missing from this retrieval.
Sources used 5
-
Alüminyum Maruziyeti ve Sağlık
This narrative review concludes that aluminum's critical adverse effect is neurotoxicity, while causal links to Alzheimer disease and breast cancer remain unproven.
DOI: 10.38079/igusabder.1228435 -
Breast cancer incidence in Spain before, during and after the implementation of screening programmes
This study analyzes breast cancer incidence trends in Spain from 1980 to 2004, revealing a decline in incidence among women aged 45 and older following the implementation of screening programs, while incidence continues to rise among younger women, likely due to lifestyle change…
DOI: 10.1093/annonc/mdq095 -
Projections of the breast cancer burden to U.S. women: 1990–2000
This study projects breast cancer incidence rates among U.S. women aged 50 and over from 1990 to 2000, highlighting a continued rise in incidence due to increased mammographic screening, followed by a predicted decline as screening rates stabilize.
DOI: 10.1016/0091-7435(91)90018-y -
International Variation in Female Breast Cancer Incidence and Mortality Rates
This study analyzes global trends in female breast cancer incidence and mortality rates, revealing significant variations across different countries and regions, with decreasing mortality in high-income countries despite rising incidence rates, while some low- and middle-income …
DOI: 10.1158/1055-9965.epi-15-0535 -
The Decrease in Breast-Cancer Incidence in 2003 in the United States
The study analyzes data from the National Cancer Institute's SEER registries, revealing a significant 6.7% decrease in the age-adjusted incidence rate of breast cancer among women in the U.S. in 2003, likely linked to reduced hormone-replacement therapy usage following the Women…
DOI: 10.1056/NEJMsr070105